News＆Topics
Dr. Janice Kang Delivered Lecture on Methods for Tailoring Cancer Vaccines at the Substrate Level
On May 18, Dr. Janice Kang, who earned her Ph.D. under Professor Chad Mirkin at Northwestern University (Chicago, Illinois, USA), visited iCONM and delivered a lecture titled “Beyond Delivery: Designing Cancer Vaccines at the Substrate Level.” She is scheduled to begin a postdoctoral fellowship under Professor Laura Kiessling at the Massachusetts Institute of Technology (MIT) in this June and requested a meeting with Professor Kazunori Kataoka (Center Director of iCONM) prior to her departure, which was arranged.
In her lecture, she focused on endoplasmic reticulum aminopeptidase 1 (ERAP1), a key regulator of the immune response. She shared fascinating insights, including how encoding its substrate into a vaccine can modulate the antigen processing pathway, resulting in enhanced antigen presentation and potent tumor-suppressing effects. In addition to Professor Kataoka, Professor Hahn, who is currently on sabbatical from POSTECH, and many iCONM researchers attended the lecture, and the Q&A session was very lively. We look forward to future collaboration following her postdoctoral fellowship at MIT.
